Immobilization of Chinese herbal medicine onto the surface-modified calcium hydrogenphosphate

Biomaterials

Volumn 24, Issue 13, 2003, Pages 2413-2422

  Lin, Feng Huei ^a   Dong, Guo Chung ^b   Chen, Ko Shao ^c   Jiang, George J ^b   Huang, Chin Wang ^b   Sun, Jui Sheng ^d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^c TATUNG UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Bioceramics; Bone graft; Calcium hydrogenphosphate; Surface modification

Indexed keywords

ABSORPTION; BONE; CALCIUM COMPOUNDS; CHEMICAL BONDS; DESORPTION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; SPECTROPHOTOMETERS; SURFACE TREATMENT;

ARTIFICIAL MATERIALS;

BIOMATERIALS;

CALCIUM PHOSPHATE DIBASIC; GUSUIBU; HERBACEOUS AGENT; HEXANMETHYLENE DIISOCYANATE; ISOCYANIC ACID DERIVATIVE; LIGAND; UNCLASSIFIED DRUG;

ARTICLE; BONE GRAFT; CHEMICAL MODIFICATION; DESORPTION; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMOBILIZATION; INFRARED SPECTROSCOPY; NONHUMAN; POWDER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPECTROPHOTOMETER; SURFACE PROPERTY; ULTRAVIOLET SPECTROPHOTOMETRY;

CHANDIPURA VIRUS;

EID: 0037409925     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(03)00031-0     Document Type: Article

References (35)

1. Gendler E. Perforated demineralized bone matrix. a new form of osteoinductive biomaterial J Biomed Mater Res. 20:1986;687-697.
2. Lemons J.E. Bioceramics. is there a difference? Clin Orthop Rel Res. 261:1990;153-158.
3. 5 glass. J Biomed Mater Res. 23:1989;631-635.
4. Ogino M., Hench L.L. Formation of calcium phosphate films on silicate glasses. J Non-Cryst Solids. 38:1980;673-677.
5. Lin F.H., Liao C.J., Liu H.C., Chen K.S., Sun J.S. Behavior of fetal rat osteoblasts cultured in vitro on the DP-bioactive glass substratum. Mater Chem Phys. 49:1997;270-276.
6. Chen T.M., Yao C.H., Wang H.J., Chou G.H., Lee T.W., Lin F.H. Evaluation of a novel malleable, biodegradable osteoconductive composite in a rabbit cranial defect model. Mater Chem Phys. 55:1998;44-50.
7. Laffargue P., Fialdes P., Frayssinet P., Rtaimate M., Hildebrand H.F., Marchandies X. Adsorption and release of insulin-like growth factor-I on porous tricalcium phosphate implant. J Biomed Mater Res. 49:2000;415-421.
8. Tabata Y., Nagano A., Muniruzzaman Md, Ikada Y. In vitro sorption and desorption of basic fibroblast growth factor from biodegradable hydrogels. Biomaterials. 19:1998;1781-1789.
9. Tabata Y., Ikada Y. Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials. 20:1999;2169-2175.
10. Kim H.D., Valentini R.F. Human osteoblast response in vitro to platelet-derived growth factor and transforming growth factor-β delivered from controlled-release polymer rods. Biomaterials. 18:1997;1175-1184.
11. Ongpipattanakul B., Nguyen T., Zioncheck T.F., Wong R., Osaka G., DeGuzman L., Lee W.P., Beck L.S. Development of tricalcium phosphate/amylopectin paste combined with recombinant human transforming growth factor beta 1 as a bone defect filler. J Biomed Mater Res. 36:1997;295-305.
12. Denissen H., van Beek E., Lö wik C., Papapoulos S., van den Hooff A. Ceramic hydroxyapatite implants for the release of bisphosphonate. Bone Miner. 25:1994;123-134.
13. Sodhi R.N.S., Grad H.A., Smith D.C. Examination by X-ray pho-toelectron spectroscopy of the adsorption of chlorhexidine on hydroxyapatite. J Dent Res. 71:1992;1493-1497.
14. Tung I.C. In vitro drug release of antibiotic-loaded porous hy-droxyapatite cement. Artif Cells Blood Substit Immobil Bio-technol. 23:1995;81-81.
15. Kano S., Yamazaki A., Otsuka R., Ohgaki M., Akao M., Aoki H. Application of hydroxyapatite-sol as drug carrier. Biomed Mater Eng. 4:1994;283-290.
16. Yu D., Wong J., Matsuda Y., Fox J.L., Higuchi W.I., Otsuka M. Self-setting hydroxyapatite cement. a novel skeletal drug delivery system for antibiotics J Pharm Sci. 81:1992;529-531.
17. Shinto Y., Uchida A., Korkusuz F., Araki N., Ono K. Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. J Bone Jt Surg. 74B:1992;600-604.
18. Otsuka M., Matsuda Y., Suwa Y., Fox J.L., Higuchi W.I. A novel skeletal drug-delivery system using self-setting calcium phosphate cement. 3. Physicochemical properties and drug release rate of bovine insulin and bovine albumin. J Pharm Sci. 83:1994;255-258.
19. Otsuka M., Matsuda Y., Suwa Y., Fox J.L., Higuchi W.I. A novel skeletal drug delivery system using self-setting calcium phosphate cement. 4. Effects of the mixing solution volume on the drug-release rate of heterogeneous aspirin-loaded cement. J Pharm Sci. 83:1994;259-263.
20. Bajpai P.K., Benghuzzi H.A. Ceramic systems for long-term de-livery of chemicals and biologicals. J Biomed Mater Res. 22:1988;1245-1266.
21. Mileti I.F., Bajpai P.K. Development of a hydroxyapatite ceramic matrix for the continuous delivery of coumadin. Biomed Sci Instrum. 31:1995;177-182.
22. Uchida A., Shinto Y., Araki N., Ono K. Slow release of anticancer drugs from porous calcium hydroxyapatite ceramic. J Orthop Res. 10:1992;440-445.
23. Otsuka M., Matsuda Y., Suwa Y., Fox J.L., Higuchi W.I. A novel skeletal drug delivery system using self-setting calcium phosphate cement. 5. Drug release behaviour from a heterogenous drug-loaded cement containing an anticancer drug. J Pharm Sci. 83:1994;1565-1568.
24. Otsuka M., Nakahigashi Y., Matsuda Y., Fox J.L., Higuchi W.I. A novel skeletal drug delivery system using self-setting calcium phosphate cement. 7. Effect of biological factors on indometh-acin release from the cement loaded on bovine bone. J Pharm Sci. 83:1994;1569-1573.
25. Benghuzzi H.A., England B.G., Bajpai P.K. Controlled release of hydrophilic compounds by resorbable and biodegradable ce-ramic drug delivery devices. Biomed Sci Instrum. 28:1992;179-182.
26. Cannon M.R., Bajpai P.K. Continuous delivery of azidothymidine by hydroxyapatite or tricalcium phosphate ceramics. Biomed Sci Instrum. 31:1995;159-164.
27. Dong G-.C., Sun J-.S., Yao C-.H., Jiang G-.J., Huang C-.W., Lin F-.H. A study on grafting and characterization of HMDI-modified calcium hydrogenphosphate. Biomaterials. 22:2001;3179-3189.
28. Ma K.C. Stimulative effects of gusuibu (Drynaria baronii) injection on chick embryo bone primordium calcification in vitro. Chung-Kuo Chung Yao Tsa Chih-China. J Chin Mater Med. 20:1995;178-180.
29. Zhou X.H. Therapeutic effect of Drynaria baronii Diels on experimental osteoarthritis. Chung Yao Tung Pao Bull Chin Mater Med. 12:1987;41-44.
30. Ma K.C., Zhu T.Y., Wang F.X. Stimulative effects of gusuibu (Drynaria baronii) injection on chick embryo bone primordium calcification in vitro. Am J Chin Med. 24:1996;77-82.
31. Liu S., Xiao Z., Feng R. A flavanol glycoside from Drynaria propinqua. Phytochemistry. 35:1994;1595-1596.
32. Liu S., Xian Z. Studies on the chemical constituents of Drynaria propinqua (wall). J SM Hua Si Yao Shue Tsa Chih. 6:1991;125-128.
33. Zhou T.S., Zhou R.H. Original plants and their taxonomic studies of crude drug Gusuibu. J China Pharm Univ Bull. 24:1993;70-72.
34. Zhou T.S., Lin D.W., Li R.Z., Zhou R.H. Identification and determination of Flavonoids in Twelve types of Gusuibu (Rhizoma Drynariae). J China Pharm Univ Bull. 27:1996;540-543.
35. Zhou F.P., Zhang Z.Q. Quality evaluation of 3 kinds of rhizoma Drynariae. Chung-Kuo Chung Yao Tsa Chih-China J Chin Mater Med. 19:1994;261-263.